167 related articles for article (PubMed ID: 21752967)
1. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
[TBL] [Abstract][Full Text] [Related]
2. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
[TBL] [Abstract][Full Text] [Related]
4. The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
Chevaliez S; Bouvier-Alias M; Rodriguez C; Soulier A; Poveda JD; Pawlotsky JM
J Clin Microbiol; 2013 Apr; 51(4):1078-82. PubMed ID: 23325825
[TBL] [Abstract][Full Text] [Related]
5. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
Pyne MT; Mallory M; Hillyard DR
J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
[TBL] [Abstract][Full Text] [Related]
7. Second-generation Cobas AmpliPrep/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay design.
Zitzer H; Heilek G; Truchon K; Susser S; Vermehren J; Sizmann D; Cobb B; Sarrazin C
J Clin Microbiol; 2013 Feb; 51(2):571-7. PubMed ID: 23241371
[TBL] [Abstract][Full Text] [Related]
8. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.
De Bel A; Marissens D; Debaisieux L; Liesnard C; Van den Wijngaert S; Lauwers S; Piérard D
J Clin Microbiol; 2010 Apr; 48(4):1337-42. PubMed ID: 20164284
[TBL] [Abstract][Full Text] [Related]
9. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
[TBL] [Abstract][Full Text] [Related]
10. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
[TBL] [Abstract][Full Text] [Related]
11. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
[TBL] [Abstract][Full Text] [Related]
12. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
14. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
16. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pierce VM; Eversley JS; Tran TK; Rosenberg ES
Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pyne MT; Hillyard DR
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
[TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.
Wolff D; Gerritzen A
Clin Chem Lab Med; 2007; 45(7):917-22. PubMed ID: 17617038
[TBL] [Abstract][Full Text] [Related]
20. Necessity for reassessment of patients with serogroup 2 hepatitis C virus (HCV) and undetectable serum HCV RNA.
Moritou Y; Ikeda F; Takeuchi Y; Seki H; Nanba S; Iwasaki Y; Yamamoto K
J Clin Microbiol; 2014 Feb; 52(2):544-8. PubMed ID: 24478486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
